Publication | Open Access

A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease

Neurodegenerative DiseasesAlzheimer's DiseaseBiomarkersNeurochemical BiomarkersNeurologyNeuroscienceTwo-step ImmunoassayAβ42/aβ40 RatioAging-associated DiseaseMedicineHuman Blood Plasma